Trial Details

COMPLETED
Basic Information
Clinical ID c1186
Identifier NCT01647516
Trial Title Efficacy and Safety Study of Ozanimod in Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: Ozanimod|DRUG: Placebo
Participant Information
Sponsor Celgene
City Anaheim
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2012-12-26
Primary Completion Date 2015-03-10
Completion Date 2019-08-30